rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Scott M. Plesha

CEO and President

Company insider

Files Form 4 as: CEO and President, Pelthos Therapeutics; President, Biodelivery Sciences International.

In numbers

Trades disclosed
64
Buys
0
Sells
5
Bought
$0
Sold
$677K
Companies
2
Companies where not an officer
0
First trade
18 Feb 2018
Last trade
2 Jul 2025
Last filed
1 Apr 2026

Companies traded

Where they are an officer
PTHS Pelthos TherapeuticsDirector, Officer · Pharmaceuticals · last 2 Jul 20250 buys · 0 sells
Biodelivery Sciences InternationalOfficer · last 22 Mar 20220 buys · 5 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
2 Jul 2025filed 1 Apr 2026PTHS Pelthos TherapeuticsPharmaceuticalsSEC FORM 4 Code A—83,678 at $0.00filing
2 Jul 2025filed 1 Apr 2026PTHS Pelthos TherapeuticsPharmaceuticalsSEC FORM 4 Code A—83,678 at $0.00filing
2 Jul 2025filed 23 Jul 2025PTHS Pelthos Therapeuticsoption or derivative · PharmaceuticalsSEC FORM 4 Code A—83,678filing
2 Jul 2025filed 23 Jul 2025PTHS Pelthos Therapeuticsoption or derivative · PharmaceuticalsSEC FORM 4 Code A—255,000filing
22 Mar 2022filed 22 Mar 2022Biodelivery Sciences Internationaloption or derivativeSEC FORM 4 Code D—119,228 at $0.00filing
22 Mar 2022filed 22 Mar 2022Biodelivery Sciences Internationaloption or derivativeSEC FORM 4 Code D—245,000 at $0.00filing
22 Mar 2022filed 22 Mar 2022Biodelivery Sciences Internationaloption or derivativeSEC FORM 4 Code D—348,222 at $0.00filing
22 Mar 2022filed 22 Mar 2022Biodelivery Sciences Internationaloption or derivativeSEC FORM 4 Code D—369,721 at $0.00filing
22 Mar 2022filed 22 Mar 2022Biodelivery Sciences InternationalSEC FORM 4 Code J—345,127 at $0.00filing
31 Jan 2022filed 31 Jan 2022Biodelivery Sciences Internationaloption or derivativeSEC FORM 4 Code M—13,334 at $0.00filing
31 Jan 2022filed 31 Jan 2022Biodelivery Sciences InternationalSEC FORM 4 Code M—10,869 at $0.00filing
31 Jan 2022filed 31 Jan 2022Biodelivery Sciences InternationalSEC FORM 4 Code M—13,334 at $0.00filing
29 Jan 2022filed 31 Jan 2022Biodelivery Sciences Internationaloption or derivativeSEC FORM 4 Code M—10,869 at $0.00filing
27 Jan 2022filed 31 Jan 2022Biodelivery Sciences Internationaloption or derivativeSEC FORM 4 Code A$1.4M369,721 at $3.66filing
27 Jan 2022filed 31 Jan 2022Biodelivery Sciences Internationaloption or derivativeSEC FORM 4 Code A—66,257 at $0.00filing
27 Jan 2022filed 31 Jan 2022Biodelivery Sciences Internationaloption or derivativeSEC FORM 4 Code M—21,050 at $0.00filing
27 Jan 2022filed 31 Jan 2022Biodelivery Sciences InternationalSEC FORM 4 Code M—21,050 at $0.00filing
12 Mar 2021filed 16 Mar 2021Biodelivery Sciences InternationalSEC FORM 4 Code A—20,834 at $0.00filing
12 Mar 2021filed 16 Mar 2021Biodelivery Sciences InternationalSEC FORM 4 Code M—20,834 at $0.00filing
12 Mar 2021filed 16 Mar 2021Biodelivery Sciences Internationaloption or derivativeSEC FORM 4 Code M—20,834 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Not placed5

Buys in green, sells in red, by the company’s sector.

Related people

Ezra M. FriedbergDirector · Director at Pelthos Therapeutics, filing Form 4 there in the last year
Peter GreenleafDirector · Director at Pelthos Therapeutics, filing Form 4 there in the last year
Matthew PaulsDirector · Director at Pelthos Therapeutics, filing Form 4 there in the last year
Todd C. DavisChief Executive Officer · Director at Pelthos Therapeutics, filing Form 4 there in the last year
Knuettel Francis IIDirector · CFO, Treas & Secty at Pelthos Therapeutics, filing Form 4 there in the last year